Ninety One (UK)
TEVA icon

Ninety One (UK)’s Teva Pharmaceuticals TEVA Stock Holding History

Ninety One (UK)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-812,021
Closed -$29.4M – 325
2016
Q4 		$29.4M Sell
812,021
-1,866,514
-70% -$74.5M 0.15% 137
2016
Q3 		$123M Buy
2,678,535
+235,821
+10% +$12.3M 0.6% 56
2016
Q2 		$123M Buy
2,442,714
+271,059
+12% +$14.4M 0.63% 56
2016
Q1 		$116M Buy
2,171,655
+1,148,997
+112% +$67.4M 0.63% 59
2015
Q4 		$67.1M Buy
1,022,658
+213,648
+26% +$13.2M 0.38% 87
2015
Q3 		$45.7M Buy
809,010
+199,442
+33% +$12.9M 0.29% 96
2015
Q2 		$36M Sell
609,568
-18,284
-3% -$1.13M 0.21% 117
2015
Q1 		$39.1M Buy
627,852
+47,332
+8% +$2.75M 0.23% 110
2014
Q4 		$33.4M Sell
580,520
-49,752
-8% -$2.77M 0.2% 115
2014
Q3 		$33.9M Buy
630,272
+6,382
+1% +$338K 0.2% 121
2014
Q2 		$32.7M Sell
623,890
-15,958
-2% -$816K 0.19% 130
2014
Q1 		$33.8M Sell
639,848
-8,514
-1% -$393K 0.23% 115
2013
Q4 		$26M Buy
648,362
+20,287
+3% +$799K 0.18% 117
2013
Q3 		$23.7M Buy
628,075
+4,345
+0.7% +$169K 0.17% 120
2013
Q2 		$24.4M Buy
+623,730
New +$24.3M 0.19% 123

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ninety One (UK)'s TEVA Position: Q1 2017 in Review

Ninety One (UK) sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 812,021 shares — an estimated $29.4M sold.

Ninety One (UK) first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $123M in Q3 2016. 688 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Ninety One (UK) reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Ninety One (UK) sold 812,021 Teva Pharmaceuticals shares in Q1 2017, an estimated $29.4M.
  • Ninety One (UK) first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Ninety One (UK)'s Teva Pharmaceuticals position peaked at $123M in Q3 2016.
  • 688 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Ninety One (UK)'s 13F filing for Q1 2017, filed 12 May 2017.